Detalhe da pesquisa
1.
The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders.
Adv Neurobiol
; 30: 37-99, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928846
2.
Selective M5 muscarinic acetylcholine receptor negative allosteric modulator VU6008667 blocks acquisition of opioid self-administration.
Neuropharmacology
; 227: 109424, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36720403
3.
M1/M4-Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice.
ACS Chem Neurosci
; 14(3): 435-457, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36655909
4.
Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder.
J Med Chem
; 65(8): 6273-6286, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417155
5.
Superior Colliculus Lesions Lead to Disrupted Responses to Light in Diurnal Grass Rats (Arvicanthis niloticus).
J Biol Rhythms
; 35(1): 45-57, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31619104
6.
Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders.
Adv Pharmacol
; 86: 153-196, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31378251
7.
Acute Negative Allosteric Modulation of M5 Muscarinic Acetylcholine Receptors Inhibits Oxycodone Self-Administration and Cue-Induced Reactivity with No Effect on Antinociception.
ACS Chem Neurosci
; 10(8): 3740-3750, 2019 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31268669